11 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EXCELLA-M SPINAL SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

STb Copper Ni-Ti

FDA UDI
ORMCO CORPORATION·00889989025033·STb STRAIGHTWIRE CUNITI 18 x 18 LG PK10

N.A.

FDA UDI
Forestadent Bernhard Förster GmbH·EFOR20421431·Arch wires Titanol Superelastic Straight-Arch-F...

BD INSULIN SYRINGE WITH BD ULTRA-FINE NEEDLE

FDA Adverse Event
Injury ·BD·Product code FMI·February 2, 2015

24 FR. LEFT HEART VENT CATHETER WITH PRESSURE MONITORING LINE, MODEL 12524

FDA 510(k)
FDA Class 2 ·Cardiovascular

DYNALINK BILIARY SELF-EXPANDING STENT SYSTEM

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

*

FDA Adverse Event
Malfunction ·MEDTRONIC XOMED·Product code GFA·March 28, 2013

LIGAMAX-5MM

FDA Adverse Event
Malfunction ·ETHICON ENDO-SURGERY, LLC.·Product code FZP·April 6, 2011

VITALITY DS

FDA Adverse Event
Malfunction ·CARDIAC PACEMAKERS, INC·Product code LWS·May 8, 2008

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Boston Scientific, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 USA. Indicated for patients who are at risk for sudden cardiac death due to ventricular arrhythmias and may require pacing support.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 23, 2013